Miniaturized shake-flask HPLC method for determination of distribution coefficient of drugs used in inflammatory bowel diseases

A new method for determination of distribution coefficient of drugs azathioprine, 6-mercaptopurine and 6-thioguanine and nutrient folic acid used in the treatment of inflammatory bowel disease based on a miniaturized shake-flask and HPLC/DAD was developed. Special attention was made to the most comm...

Full description

Bibliographic Details
Main Authors: Brusač Edvin, Jeličić Mario-Livio, Klarić Daniela Amidžić, Mornar Ana
Format: Article
Language:English
Published: Sciendo 2019-12-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.2478/acph-2019-0046
id doaj-0a70085420c440c996a2eebca6010c04
record_format Article
spelling doaj-0a70085420c440c996a2eebca6010c042021-09-06T19:40:59ZengSciendoActa Pharmaceutica1846-95582019-12-0169464966010.2478/acph-2019-0046acph-2019-0046Miniaturized shake-flask HPLC method for determination of distribution coefficient of drugs used in inflammatory bowel diseasesBrusač Edvin0Jeličić Mario-Livio1Klarić Daniela Amidžić2Mornar Ana3University of Zagreb, Faculty of Pharmacy and Biochemistry10 000Zagreb, CroatiaUniversity of Zagreb, Faculty of Pharmacy and Biochemistry10 000Zagreb, CroatiaUniversity of Zagreb, Faculty of Pharmacy and Biochemistry10 000Zagreb, CroatiaUniversity of Zagreb, Faculty of Pharmacy and Biochemistry10 000Zagreb, CroatiaA new method for determination of distribution coefficient of drugs azathioprine, 6-mercaptopurine and 6-thioguanine and nutrient folic acid used in the treatment of inflammatory bowel disease based on a miniaturized shake-flask and HPLC/DAD was developed. Special attention was made to the most commonly reported problems in the measurement of distribution coefficients using a shake-flask method such as mixing technique, speed and time, the temperature of experiment, type of buffer and its pH as well as n-octanol/buffer phase ratio. The concentration of compounds in the buffer is determined by HPLC directly from shake flasks or conventional 2-mL vials. The developed method was fully validated according to ICH guidelines. Furthermore, experimental data were successfully compared with lipophilicity and human intestinal absorption calculated by the use of four different theoretical approaches. The method shows potential for high-throughput measurements of a large number of compounds.https://doi.org/10.2478/acph-2019-0046distribution coefficient logarithmshake-flaskhplcin silicoinflammatory bowel disease
collection DOAJ
language English
format Article
sources DOAJ
author Brusač Edvin
Jeličić Mario-Livio
Klarić Daniela Amidžić
Mornar Ana
spellingShingle Brusač Edvin
Jeličić Mario-Livio
Klarić Daniela Amidžić
Mornar Ana
Miniaturized shake-flask HPLC method for determination of distribution coefficient of drugs used in inflammatory bowel diseases
Acta Pharmaceutica
distribution coefficient logarithm
shake-flask
hplc
in silico
inflammatory bowel disease
author_facet Brusač Edvin
Jeličić Mario-Livio
Klarić Daniela Amidžić
Mornar Ana
author_sort Brusač Edvin
title Miniaturized shake-flask HPLC method for determination of distribution coefficient of drugs used in inflammatory bowel diseases
title_short Miniaturized shake-flask HPLC method for determination of distribution coefficient of drugs used in inflammatory bowel diseases
title_full Miniaturized shake-flask HPLC method for determination of distribution coefficient of drugs used in inflammatory bowel diseases
title_fullStr Miniaturized shake-flask HPLC method for determination of distribution coefficient of drugs used in inflammatory bowel diseases
title_full_unstemmed Miniaturized shake-flask HPLC method for determination of distribution coefficient of drugs used in inflammatory bowel diseases
title_sort miniaturized shake-flask hplc method for determination of distribution coefficient of drugs used in inflammatory bowel diseases
publisher Sciendo
series Acta Pharmaceutica
issn 1846-9558
publishDate 2019-12-01
description A new method for determination of distribution coefficient of drugs azathioprine, 6-mercaptopurine and 6-thioguanine and nutrient folic acid used in the treatment of inflammatory bowel disease based on a miniaturized shake-flask and HPLC/DAD was developed. Special attention was made to the most commonly reported problems in the measurement of distribution coefficients using a shake-flask method such as mixing technique, speed and time, the temperature of experiment, type of buffer and its pH as well as n-octanol/buffer phase ratio. The concentration of compounds in the buffer is determined by HPLC directly from shake flasks or conventional 2-mL vials. The developed method was fully validated according to ICH guidelines. Furthermore, experimental data were successfully compared with lipophilicity and human intestinal absorption calculated by the use of four different theoretical approaches. The method shows potential for high-throughput measurements of a large number of compounds.
topic distribution coefficient logarithm
shake-flask
hplc
in silico
inflammatory bowel disease
url https://doi.org/10.2478/acph-2019-0046
work_keys_str_mv AT brusacedvin miniaturizedshakeflaskhplcmethodfordeterminationofdistributioncoefficientofdrugsusedininflammatoryboweldiseases
AT jelicicmariolivio miniaturizedshakeflaskhplcmethodfordeterminationofdistributioncoefficientofdrugsusedininflammatoryboweldiseases
AT klaricdanielaamidzic miniaturizedshakeflaskhplcmethodfordeterminationofdistributioncoefficientofdrugsusedininflammatoryboweldiseases
AT mornarana miniaturizedshakeflaskhplcmethodfordeterminationofdistributioncoefficientofdrugsusedininflammatoryboweldiseases
_version_ 1717767284775190528